 NEW YORK, Aug. 16, 2021 PRNewswire -- Pomerantz LLP is investigating claims on behalf of investors of Rigel Pharmaceuticals, Inc. Rigel or the Company NASDAQ: RIGL. Such investors are advised to contact Robert S. 